Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy
出版年份 2016 全文链接
标题
Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy
作者
关键词
-
出版物
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 46, Issue 3, Pages 513-522
出版商
Wiley
发表日期
2016-01-17
DOI
10.1002/eji.201445388
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase I study of BMS-663513, a fully human anti-CD137 agonist monoclonal antibody, in patients (pts) with advanced cancer (CA)
- (2017) M. Sznol et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2R null Immunodeficient Mice
- (2015) M. F. Sanmamed et al. CANCER RESEARCH
- ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment
- (2015) L. E. Lamberts et al. CLINICAL CANCER RESEARCH
- Phenotypic switch of CD8+T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells
- (2015) Romain Vuillefroy de Silly et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- c-IAP ubiquitin protein ligase activity is required for 4-1BB signaling and CD8+memory T-cell survival
- (2015) Maria Letizia Giardino Torchia et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inhibitory receptors as targets for cancer immunotherapy
- (2015) Meghan E. Turnis et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Hematopoietic stem cell quiescence and function are controlled by the CYLD–TRAF2–p38MAPK pathway
- (2015) Melania Tesio et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD137 Agonist Therapy Can Reprogram Regulatory T Cells into Cytotoxic CD4+T Cells with Antitumor Activity
- (2015) Ilseyar Akhmetzyanova et al. JOURNAL OF IMMUNOLOGY
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
- (2015) Alfred L. Garfall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+tumors when combined with an E6/E7 peptide vaccine
- (2015) Todd Bartkowiak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
- (2015) Bettina Weigelin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
- (2015) A. R. Sanchez-Paulete et al. Cancer Discovery
- SA-4-1BBL and Monophosphoryl Lipid A Constitute an Efficacious Combination Adjuvant for Cancer Vaccines
- (2014) A. K. Srivastava et al. CANCER RESEARCH
- Curing Mice with Large Tumors by Locally Delivering Combinations of Immunomodulatory Antibodies
- (2014) M. Dai et al. CLINICAL CANCER RESEARCH
- Immuno-oncology Combinations: A Review of Clinical Experience and Future Prospects
- (2014) S. J. Antonia et al. CLINICAL CANCER RESEARCH
- Targeting CD137 enhances the efficacy of cetuximab
- (2014) Holbrook E. Kohrt et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
- (2014) Shravan Madireddi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ERK-Dependent Bim Modulation Downstream of the 4-1BB-TRAF1 Signaling Axis Is a Critical Mediator of CD8 T Cell Survival In Vivo
- (2014) L. Sabbagh et al. JOURNAL OF IMMUNOLOGY
- 4-1BB Ligand Signaling to T Cells Limits T Cell Activation
- (2014) So-Young Eun et al. JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
- (2014) Zineb Belcaid et al. PLoS One
- Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapy
- (2014) Huafeng Wei et al. OncoImmunology
- Combined Immunostimulatory Monoclonal Antibodies Extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model
- (2013) A. Morales-Kastresana et al. CLINICAL CANCER RESEARCH
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Regulation of NF-κB by ubiquitination
- (2013) Jueqi Chen et al. CURRENT OPINION IN IMMUNOLOGY
- Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice
- (2013) Kritika Kachapati et al. JOURNAL OF AUTOIMMUNITY
- Inducible Tumor Necrosis Factor (TNF) Receptor-associated Factor-1 Expression Couples the Canonical to the Non-canonical NF-κB Pathway in TNF Stimulation
- (2013) Sanjeev Choudhary et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- T Cell Costimulation with Anti-CD137 Monoclonal Antibodies Is Mediated by K63-Polyubiquitin-Dependent Signals from Endosomes
- (2013) I. Martinez-Forero et al. JOURNAL OF IMMUNOLOGY
- Leukocyte-specific protein 1 links TNF receptor-associated factor 1 to survival signaling downstream of 4-1BB in T cells
- (2013) Laurent Sabbagh et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
- (2013) Jessica Ann Chacon et al. PLoS One
- Antitumor activities of agonistic anti-TNFR antibodies require differential Fc RIIB coengagement in vivo
- (2013) F. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncolytic Virus and Anti-4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
- (2012) L. B. John et al. CANCER RESEARCH
- Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies
- (2012) I. Verbrugge et al. CANCER RESEARCH
- Ubiquitination in signaling to and activation of IKK
- (2012) Zhijian J. Chen IMMUNOLOGICAL REVIEWS
- Opposing Roles for TRAF1 in the AlternativeversusClassical NF-κB Pathway in T Cells
- (2012) Ann J. McPherson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
- (2012) Holbrook E. Kohrt et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12
- (2012) José I Quetglas et al. MOLECULAR THERAPY
- Pharmacokinetics and Biodistribution of a Human Monoclonal Antibody to Oxidized LDL in Cynomolgus Monkey Using PET Imaging
- (2012) Amrita V. Kamath et al. PLoS One
- The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
- (2012) Asís Palazón et al. Cancer Discovery
- Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation
- (2012) Adam J. Adler et al. OncoImmunology
- CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo
- (2011) D.-G. Song et al. BLOOD
- In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
- (2011) D.-G. Song et al. CANCER RESEARCH
- Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes
- (2011) A. Palazon et al. CANCER RESEARCH
- Novel Phosphorylation-dependent Ubiquitination of Tristetraprolin by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase Kinase 1 (MEKK1) and Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)
- (2011) Yvonne M. Schichl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interaction with Fc RIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
- (2011) A. L. White et al. JOURNAL OF IMMUNOLOGY
- Inhibitory Fc Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
- (2011) F. Li et al. SCIENCE
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy
- (2011) Roch Houot et al. TRENDS IN IMMUNOLOGY
- CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
- (2010) H. E. Kohrt et al. BLOOD
- Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
- (2010) Juan Dubrot et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- 4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines
- (2010) R. K. Sharma et al. CANCER RESEARCH
- Intratumoral injection of interferon-α and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy
- (2010) Juan Dubrot et al. INTERNATIONAL JOURNAL OF CANCER
- Combination Therapy of Established Tumors by Antibodies Targeting Immune Activating and Suppressing Molecules
- (2010) K. Takeda et al. JOURNAL OF IMMUNOLOGY
- Asymmetric Recruitment of cIAPs by TRAF2
- (2010) Peter D. Mace et al. JOURNAL OF MOLECULAR BIOLOGY
- Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies
- (2010) Paolo A. Ascierto et al. SEMINARS IN ONCOLOGY
- Structural Basis for the Lack of E2 Interaction in the RING Domain of TRAF2
- (2009) Qian Yin et al. BIOCHEMISTRY
- Lysine 63 Polyubiquitination in Immunotherapy and in Cancer-promoting Inflammation
- (2009) I. Martinez-Forero et al. CLINICAL CANCER RESEARCH
- In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb
- (2009) Oihana Murillo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Structure of the Trimer of Human 4-1BB Ligand Is Unique among Members of the Tumor Necrosis Factor Superfamily
- (2009) Eun-Young Won et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy
- (2009) Y. H. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Ubiquitylation in innate and adaptive immunity
- (2009) Vijay G. Bhoj et al. NATURE
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
- (2009) C. Carpenito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination Therapy with Cisplatin and Anti-4-1BB: Synergistic Anticancer Effects and Amelioration of Cisplatin-Induced Nephrotoxicity
- (2008) Y. H. Kim et al. CANCER RESEARCH
- Immune regulation and control of regulatory T cells by OX40 and 4-1BB
- (2008) Takanori So et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities
- (2008) Matthias Wölfl et al. CYTOMETRY PART A
- Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies
- (2008) Ignacio Melero et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now